Advocacy
Advocacy for patient access and equity.
23 articles · updated Sep 26
Guides
New
guide
How to contact your lawmakers about GLP-1 coverage: a step-by-step guide
Congressional staff say individualized contact from constituents sways undecided lawmakers, but most messages leave out what staff find useful. This guide shows how to find your federal and state legislators, match your ask to the right level of government (TROA, the Medicare fix, state mandates, Medicaid), pick a channel, tell your story, and follow up, with a call script and email template.
guide
FDA's proposal to keep compounded GLP-1s off the 503B bulks list — and how to comment
In May 2026 the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list, a decision that affects how compounded GLP-1s can be made. The public comment period closed July 30, 2026, and as of late September 2026 the FDA has not published a final determination. This guide explains the proposal, why it matters for access, and what you can still do.
guide
The Treat and Reduce Obesity Act (H.R. 4231 / S. 1973): what it is and why it matters
TROA is the main federal bill aimed at ending Medicare's exclusion of obesity medications. It was first introduced in 2013 and has been reintroduced with bipartisan support in later Congresses, but it hasn't passed. This guide explains what it would change.
guide
Escalation paths beyond your insurer: commissioners, ombudsmen, and external review
When your insurer's internal appeals are exhausted, you still have options: independent external review, state regulators, the Department of Labor for self-funded employer plans, and state consumer assistance programs or health insurance advocates. Who does what, and when each applies.
guide
What to say when your employer's benefits team says no
A "no" from HR or benefits often just means this plan year's decision has already been made. How to respond, what to ask, and how to keep the door open for next year.
guide
How to write an effective insurance appeal letter
A strong appeal letter answers the specific denial reason with specific documentation. A structure to work from, plus what to do after you send it.
guide
Advocating for coverage when you don't have a qualifying diagnosis code yet
Coverage criteria are often built around a BMI threshold or a diagnosis code, and real health risk doesn't always line up with those numbers. How to build a case when you don't yet technically qualify.
guide
The compounding pharmacy debate: patient access vs. safety regulation
When brand-name GLP-1 supply couldn't meet demand, compounded versions filled the gap for many patients who couldn't otherwise afford or get treatment. Those shortages ended in December 2024 (tirzepatide) and February 2025 (semaglutide), and the argument over access versus safety has continued since.
guide
Why GLP-1 access is uneven across income and race
Few eligible adults get a GLP-1 prescription at all, and the gaps follow insurance type, employer size, where you live and, in some settings, race and ethnicity. What the studies show and what drives the differences.
guide
Weight stigma in healthcare settings: how to advocate for yourself with a dismissive provider
Weight stigma in clinical care is a documented barrier to good treatment. How to recognize it, what to say in the room, and when to find a different provider.
guide
Talking to friends and family who are skeptical about GLP-1 use
"Isn't that the easy way out?" How to answer skepticism from people close to you, based on what GLP-1 medications are and do, without feeling you have to justify your medical decisions to everyone.
guide
Obesity as a chronic disease vs. a lifestyle choice: why the framing matters
Whether obesity is seen as a chronic disease or a personal failing affects insurance coverage, the care you get in a doctor's office, and how people react to your treatment. Where medicine stands on the question, and why the framing is worth advocating for.
guide
What a successful insurance appeal campaign looks like
A denial letter usually starts a process with several stages, deadlines and an independent review at the end. What a well-run appeal includes, and why so few people use the steps available to them.
guide
Sharing your story: how patient testimonials influence coverage decisions and legislation
Congressional staff say personal stories are helpful and that they rarely get them. Where your GLP-1 coverage story can be used, how to tell it so it's useful, and what to check before you share it.
guide
How to find and join a GLP-1 patient advocacy or support community
Where to find GLP-1 patient communities and advocacy groups, how to tell peer support from organized advocacy, and the warning signs that a group isn't as neutral as it looks.
guide
The role of patient advocacy organizations in obesity treatment policy
Coverage and policy change rarely come from one person's effort. What patient advocacy organizations do, how to judge one (including its funding), and how to take part without just donating.
guide
How employer self-funded plans decide GLP-1 coverage, and how to make the case for adding it
If your employer is self-funded, it decides whether GLP-1s are covered, and it revisits that decision every year. How those decisions get made, and how to make a credible case for change.
guide
The push to get Medicare to cover GLP-1 medications for obesity
Medicare is legally barred from covering weight-loss drugs, yet it covers the same medications for diabetes or heart disease. As of September 2026, a temporary CMS demonstration called the GLP-1 Bridge lets eligible beneficiaries get certain GLP-1s for about $50 a month while the underlying exclusion stays in place. This guide explains why the gap exists, what the Bridge does and doesn't change, and how patients and advocates are pushing for a permanent fix.
guide
How GLP-1 coverage mandates differ by state
A few states require some insurance plans to cover obesity treatment, including GLP-1 medications; most don't. This guide covers how state mandates work, why they skip most people with job-based insurance, and how to find out what your state requires.
Conversation guides
Glossary terms
- Obesity Action Coalition (OAC) — A U.S. nonprofit patient advocacy organization focused on obesity education, awareness, and access to treatment.
Resources
- Obesity Action Coalition (official site) — The official site of the Obesity Action Coalition, a national patient advocacy nonprofit: education, community support and advocacy resources for people affected by obesity.
- The Obesity Society — The leading U.S.-based professional society for obesity science and treatment. Its position statements, journal and annual ObesityWeek meeting are useful sources for patients and advocates.